Updated Date:
27 Nov 2025
Product Detail:
RUBIFEN LA methylphenidate hydrochloride 20 mg modified release capsules blister pack
Shortage Status:
Current
AUST R:
362231
Availability:
Unavailable
Active Ingredient:
methylphenidate hydrochloride
Reason:
Unexpected increase in demand due to other sponsors unable to supply
Dosage Form:
Capsule,hard
Supply Impact Dates
From 28 Jul 2025
To 30 Jun 2026
Management Action:
Patients are advised to consult their healthcare professional to discuss their options. Overseas registered alternative products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. An updated TGA web statement is available at: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products .
